Hepatitis Monthly
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 0.5 | Q4 | 5.9% | 0.181 | Q4 | 23.7% |
| 2024 | 0.6 | Q4 | 8.8% | 0.196 | Q4 | 30.0% |
| 2023 | 0.3 | Q4 | 7.3% | 0.201 | Q4 | 35.3% |
| 2022 | 0.6 | Q4 | 10.3% | 0.208 | Q4 | 38.7% |
| 2021 | 1.2 | Q4 | 38.2% | 0.210 | Q4 | 40.5% |
| 2020 | — | — | 0.264 | Q4 | 46.1% | |
| 2019 | — | — | 0.441 | Q3 | 63.7% | |
| 2018 | — | — | 0.509 | Q3 | 65.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1735-143X
ISSN
1735-3408
country
NLcoverage
2007-2025